Atlas Trials

A Study to Evaluate the Effect of AZD6793 on the Pharmacokinetics and Pharmacodynamics of Metformin in Participants With Type 2 Diabetes Mellitus

Clinical trial NCT07433062 · SUSPENDED

Trial details

NCT number
NCT07433062
Sponsor
AstraZeneca
Status
SUSPENDED
Phase
Phase 1
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2026-01-14
Primary completion
2026-06-18
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.